Drug details
Idamycin (idarubicin)
type of Antineoplastics, Anthracycline
Idamycin (idarubicin hydrochloride) for Injection is an antineoplastic (anticancer) anthracycline used to treat leukemia. The brand name Idamycin is discontinued, but generic versions may be available.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- itching,
- rash,
- easy bruising,
- unusual bleeding,
- confusion,
- mental or mood changes,
- vomit that looks like coffee grounds
- severe dizziness,
- black or bloody stools,
- severe abdominal pain,
- numbness or tingling of arms and legs,
- blisters on palms of hands or soles of the feet,
- pain or sores in the mouth or throat,
- small red spots on the skin,
- bloody urine, and
The following drugs are related to Idamycin, either as a replacement or used together:
- Arzerra (ofatumumab injection)
- Erwinaze (asparaginase erwinia chrysanthemi)
- Symbenda (bendamustine hydrochloride)
- Bendeka (bendamustine hydrochloride injection)
- Bosulif (bosutinib tablets)
- Oforta (fludarabine phosphate tablets)
- Gazyva (obinutuzumab injection)
- Jakafi (ruxolitinib)
- Jylamvo (methotrexate oral solution)
- Kymriah (tisagenlecleucel suspension for intravenous infusion)
- Purinethol (mercaptopurine)
- Purixan (mercaptopurine oral suspension)
- Monjuvi (tafasitamab-cxix injection)
- Rezlidhia (olutasidenib capsules)
The following supplements are related to Idamycin, and may be used together with the drug:
- Saccharomyces Boulardii (s.)
- Arsenic (s.)
- Transfer Factor (s.)